Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
10.52
+0.72 (7.35%)
At close: Sep 5, 2025, 4:00 PM
10.37
-0.15 (-1.43%)
After-hours: Sep 5, 2025, 7:46 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Biotechnology
14.02M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
14.02M